Business Description
Alligator Bioscience AB
ISIN : SE0000767188
Compare
Compare
Traded in other countries / regions
ATORX.Sweden7AL.Germany0RK9.UK IPO Date
2016-11-23Description
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.11 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 1.36 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -15.55 | |||||
| Beneish M-Score | -4.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 52 | |||||
| 3-Year EBITDA Growth Rate | 22 | |||||
| 3-Year EPS without NRI Growth Rate | 23.3 | |||||
| 3-Year FCF Growth Rate | 29.1 | |||||
| 3-Year Book Growth Rate | -72.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.33 | |||||
| 9-Day RSI | 34.36 | |||||
| 14-Day RSI | 38.22 | |||||
| 6-1 Month Momentum % | 163.96 | |||||
| 12-1 Month Momentum % | 108 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.79 | |||||
| Quick Ratio | 0.79 | |||||
| Cash Ratio | 0.67 | |||||
| Days Sales Outstanding | 53.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -69.9 | |||||
| Shareholder Yield % | -27.84 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -429.19 | |||||
| Net Margin % | -427.81 | |||||
| FCF Margin % | -329.99 | |||||
| ROE % | -375.32 | |||||
| ROA % | -151.92 | |||||
| ROIC % | -214.38 | |||||
| ROC (Joel Greenblatt) % | -1015.13 | |||||
| ROCE % | -317.92 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.11 | |||||
| PB Ratio | 50.94 | |||||
| EV-to-EBIT | -2.38 | |||||
| EV-to-EBITDA | -2.49 | |||||
| EV-to-Revenue | 10.16 | |||||
| EV-to-FCF | -3.36 | |||||
| Earnings Yield (Greenblatt) % | -42.01 | |||||
| FCF Yield % | -29.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alligator Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 58.107 | ||
| EPS (TTM) (kr) | -0.54 | ||
| Beta | 0 | ||
| Volatility % | 99.66 | ||
| 14-Day RSI | 38.22 | ||
| 14-Day ATR (kr) | 0.057059 | ||
| 20-Day SMA (kr) | 0.99015 | ||
| 12-1 Month Momentum % | 108 | ||
| 52-Week Range (kr) | 0.34 - 1.568 | ||
| Shares Outstanding (Mil) | 758.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alligator Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alligator Bioscience AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alligator Bioscience AB Frequently Asked Questions
What is Alligator Bioscience AB(OSTO:ATORX)'s stock price today?
The current price of OSTO:ATORX is kr0.85. The 52 week high of OSTO:ATORX is kr1.57 and 52 week low is kr0.34.
When is next earnings date of Alligator Bioscience AB(OSTO:ATORX)?
The next earnings date of Alligator Bioscience AB(OSTO:ATORX) is 2024-05-06.
Does Alligator Bioscience AB(OSTO:ATORX) pay dividends? If so, how much?
Alligator Bioscience AB(OSTO:ATORX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers